Max Houry

Chief Operating Officer at ATB Therapeutics

Speaker

Max is co‑founder and Chief Operating Officer of ATB Therapeutics. He oversees global operations, strategy execution, and technology development, playing a central role in building the company’s intellectual property portfolio and advancing its proprietary “atbody” platform. He has contributed to taking ATB Therapeutics from an theoretical concept to a well‑funded biotech. Before launching ATB Therapeutics, Max worked as a freelance business developer in the biotech sector, advising companies on strategy, partnerships, and technology valorization, including work with Masthercell, later acquired by Catalent. This dual exposure to science and business has shaped his entrepreneurial approach, focused on translating cutting‑edge research into promising therapeutics.

Max Houry holds an MSc in Molecular Biology as well as a combined master's degree in management and SME Creation from UCLouvain (Université Catholique de Louvain), reflecting his interdisciplinary background at the intersection of life sciences and entrepreneurship.